1. Signaling Pathways
  2. Apoptosis
  3. TNF Receptor
  4. TNF Receptor Inhibitors

TNF Receptor Inhibitors

TNFRSF1A/CD120a

TNFRSF5/CD40

TNFRSF6/Fas/CD95

TNFRSF8/CD30

TNFRSF9/4-1BB/CD137

TNFRSF16/NGF Receptor/CD271

TNFRSF18/GITR/CD357

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

TNF Receptor Inhibitors, Agonists, Antagonists & Activators
Product Name TNFRSF1A/CD120a TNFRSF5/CD40 TNFRSF6/Fas/CD95 TNFRSF8/CD30 TNFRSF9/4-1BB/CD137 TNFRSF16/NGF Receptor/CD271 TNFRSF18/GITR/CD357 Purity
Etanercept    
Fas
        99.20%
R-7050  
CD40
          98.55%
Oxazolone
TNFR1
            ≥98.0%
Utomilumab        
4-1BB
   
TNF-α-IN-2  
CD40, IC50: 25 nM
          98.75%
BIO8898  
CD40L, IC50: 25 μM
          99.88%
Brentuximab      
CD30
      98.99%
Golimumab  
CD40
          99.71%
KR-33493    
Fas
        99.75%
Iscalimab  
CD40, IC50: 0.3 nM
          99.25%
Taurohyodeoxycholic acid sodium
TNFR1
            99.60%
Lucatumumab  
CD40
          98.18%
Mitazalimab  
CD40
          98.74%
GSK2245035  
CD40, pEC50: 6.5
          99.85%
Ragifilimab            
GITR
Toralizumab  
CD40L
         
AQX-016A  
CD40
          98.00%
DRI-C25441  
CD40, IC50: 0.36 μM
          99.53%
HDMAPP triammonium
TNFRSF1A
           
Letolizumab  
CD40L
         
Ravagalimab  
CD40, EC50: 3.7 nM
          99.31%
Cinrebafusp alfa        
4-1BB, Kd: 5 nM
    98.53%
DRI-C21041  
CD40L, IC50: 0.31 μM
         
Anti-inflammatory agent 17  
TNF-α, IC50: 2.576 μM
         
Relfovetmab          
NGF
 
Ranevetmab          
NGF
 
TNF-α-IN-14  
TNF-α, IC50: 1.1 μM
         
Semapimod  
CD40
         
Tecaginlimab  
CD40
   
4-1BB
    99.00%
(E)-C-HDMAPP ammonium
TNFRSF1A
           
TNF-α-IN-15  
TNF-α
         
TNF-α-IN-12  
TNF-α
         
Cudraflavone B
TNFRSF1A